Realgar transforming solution suppresses angiogenesis and tumor growth by inhibiting VEGF receptor 2 signaling in vein endothelial cells

Arsenic sulfide induces apoptosis and autophagy through the activation of ROS/JNK and suppression of Akt/mTOR signaling pathways in osteosarcoma

(2017) Gangyang Wang et al.   FREE RADICAL BIOLOGY AND MEDICINE

Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas

(2017) Robert Roskoski   PHARMACOLOGICAL RESEARCH

Realgar transforming solution displays anticancer potential against human hepatocellular carcinoma HepG2 cells by inducing ROS

(2016) Peng Song et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Angiogenesis in melanoma: an update with a focus on current targeted therapies

(2016) George Jour et al.   JOURNAL OF CLINICAL PATHOLOGY

The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy

(2016) Shengyan Xi et al.   JOURNAL OF ETHNOPHARMACOLOGY

The chick embryo chorioallantoic membrane (CAM). A multifaceted experimental model

(2016) Domenico Ribatti   MECHANISMS OF DEVELOPMENT

Synthesis and characterization of MFe2O4 (M = Co, Ni, Mn) magnetic nanoparticles for modulation of angiogenesis in chick chorioallantoic membrane (CAM)

(2015) Momin Nooris et al.   EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS

In utero arsenic exposure in mice and early life susceptibility to cancer

(2015) Michael R. Garry et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Microbial Biotransformation to Obtain New Antifungals

(2015) Luiz F. Bianchini et al.   Frontiers in Microbiology

Reversal Effect of Arsenic Sensitivity in Human Leukemia Cell Line K562 and K562/ADM Using Realgar Transforming Solution

(2013) Xin Wang et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in vitro and in vivo

(2013) Sarita Saraswati et al.   CANCER LETTERS

Realgar bioleaching solution is a less toxic arsenic agent in suppressing the Ras/MAPK pathway in Caenorhabditis elegans

(2013) Dongling Liu et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

VEGFA and tumour angiogenesis

(2013) L. Claesson-Welsh et al.   JOURNAL OF INTERNAL MEDICINE

In utero and early life arsenic exposure in relation to long-term health and disease

(2013) Shohreh F. Farzan et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Antiangiogenic Therapy for Cancer: An Update

(2012) Belal Al-Husein et al.   PHARMACOTHERAPY

From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia

(2011) S.-J. Chen et al.   BLOOD

SKLB1002, a Novel Potent Inhibitor of VEGF Receptor 2 Signaling, Inhibits Angiogenesis and Tumor Growth In Vivo

(2011) S. Zhang et al.   CLINICAL CANCER RESEARCH

Bioleaching of realgar by Acidithiobacillus ferrooxidans using ferrous iron and elemental sulfur as the sole and mixed energy sources

(2010) Peng Chen et al.   BIORESOURCE TECHNOLOGY

Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery

(2009) Qi-Hong Zhao et al.   MEDICAL ONCOLOGY

Biological extraction of realgar byAcidithiobacillus ferrooxidansand itsin vitroandin vivoantitumor activities

(2009) Xu Zhang et al.   PHARMACEUTICAL BIOLOGY